Occudo Quantitative Strategies LP Morphic Holding, Inc. Transaction History

Occudo Quantitative Strategies LP

  • $542 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$21.33 - $59.42 $311,887 - $868,839
14,622 New
14,622 $334,000
Q3 2022

Nov 14, 2022
SELL
$22.23 - $33.37 $95,944 - $144,024
-4,316 Reduced 17.66%
20,128 $570,000
Q2 2022

Aug 15, 2022
BUY
$19.74 - $43.01 $482,524 - $1.05 Million
24,444 New
24,444 $530,000

Others Institutions Holding MORF

# of Institutions
140
Shares Held
38.7M
Call Options Held
4.2K
Put Options Held
200K
View Full List

About Morphic Holding, Inc.

MORF Quotes by TradingView
  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email